logo

For the Inventor, By the Inventor

Irvine, CA, United States of America

Paul S Ripley

USPTO Granted Patents = 14


Average Co-Inventor Count = 2.7

ph-index = 12

Forward Citations = 401(Granted Patents)


Company Filing History:

goldMedal12 out of 2,285 
 
Allergan, Inc.
 patents
silverMedal2 out of 2 
 
Allegan, Inc.
 patents

Years Active: 1991-1998

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 5736165 - In-the-eye use of chlorine dioxide-containing compositions (1998-04-07),
2. 5424078 - Aqueous ophthalmic formulations and methods for preserving same (1995-06-13),
3. 5338480 - Compositions and methods to clean contact lenses (1994-08-16),
4. 5336434 - Methods, compositions and apparatus to disinfect lenses (1994-08-09),
5. 5324447 - Method and activator compositions to disinfect lenses (1994-06-28),
6. 5320806 - Methods to disinfect contact lenses (1994-06-14),
7. 5306440 - Methods for generating chlorine dioxide and compositions for disinfecting (1994-04-26),
8. 5279673 - Methods to disinfect contact lenses (1994-01-18),
9. 5246662 - Methods for generating chlorine dioxide and compositions for disinfecting (1993-09-21),
10. 5213760 - Overworn lens signaling methodology (1993-05-25),
11. 5152912 - Chlorine dioxide precursor containing compositions useful in (1992-10-06),
12. 5135623 - Methods to disinfect contact lenses (1992-08-04),
13. 5078908 - Methods for generating chlorine dioxide and compositions for disinfecting (1992-01-07),
14. 4997626 - Methods to disinfect contact lenses (1991-03-05),

Title: The Innovations of Paul S. Ripley: A Pioneer in Ophthalmic Antiseptics

Introduction

Paul S. Ripley is an accomplished inventor based in Irvine, CA, known for his significant contributions to the field of ophthalmology. With a total of 14 patents to his name, Ripley has dedicated his career to advancing innovative solutions in eye care. His research and inventions have laid the groundwork for important advancements in safe and effective treatments for ophthalmic applications.

Latest Patents

Among his notable inventions, two of Ripley's latest patents focus on the use of chlorine dioxide in ophthalmic formulations. The first patent, titled "In-the-eye use of chlorine dioxide-containing compositions," highlights the effectiveness of low concentrations of chlorine dioxide as ophthalmic antiseptics and surgical irrigants. This innovation provides a revolutionary approach to eye care, ensuring safety and efficacy for patients undergoing treatment.

The second patent, "Aqueous ophthalmic formulations and methods for preserving same," emphasizes the stabilization of chlorine dioxide as a preservative in ophthalmic formulations. It outlines the optimal range for the inclusion of chlorine dioxide and details the necessary components to maintain an appropriate tonicity and pH level in the solution. These inventions showcase Ripley's commitment to improving ophthalmic health through innovative chemical formulations.

Career Highlights

Throughout his career, Paul S. Ripley has worked with prominent companies such as Allergan, Inc. and Allegan, Inc. His collaborations with these organizations have enabled him to translate his innovative ideas into practical applications that benefit the field of ophthalmology. Ripley’s work not only represents individual achievement but also contributes broadly to advancements in eye care.

Collaborations

In addition to his work with renowned companies, Ripley has collaborated with talented professionals in his field, including Anthony J. Dziabo and Hampar Karageozian. These partnerships have fostered valuable exchanges of ideas and expertise, pushing the boundaries of ophthalmic research and product development.

Conclusion

Paul S. Ripley's extensive work and inventive spirit have established him as a significant figure in the field of ophthalmology. His innovative contributions, particularly in the realm of chlorine dioxide applications, exemplify the potential for scientific advancements to improve patient health and safety. As he continues to explore new frontiers in eye care, Ripley remains a pivotal force in shaping the future of ophthalmic treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…